Eli Lilly's earnings rally is not done yet — plus, why TJX has stayed resilient in the volatility

  • 📰 CNBC
  • ⏱ Reading Time:
  • 9 sec. here
  • 17 min. at publisher
  • 📊 Quality Score:
  • News: 59%
  • Publisher: 72%

Breaking News: Business News

Biotechnology,Pharmaceuticals,S&P 500 Index

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Mixed Markets: The S & P 500 is trying to finish the week out on a higher note after fluctuating between gains and losses for a good chunk of the session.

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Amazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbookAmazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbook
Source: Investingcom - 🏆 450. / 53 Read more »

10 things to watch in the stock market Friday, including tech rotation and Eli Lilly approvalThe S&P 500 and Nasdaq Composite were little unchanged in premarket trading as tech stocks look to stabilize after a rotation from 2024 winners.
Source: CNBC - 🏆 12. / 72 Read more »